In prepared testimony for his appearance before the US House Energy and Commerce subcommittee on Health on Thursday, Rick Bright said he was removed as the director of the Biomedical Advanced Research and Development Authority because he was raising the alarm about the coronavirus early this year and also resisting pressure from the Trump administration to promote an “unproven drug, hydroxychloroquine, to the American people without transparent information on the potential health risks.”
In prepared testimony for his appearance before the US House Energy and Commerce subcommittee on Health on Thursday, Rick Bright said he was removed as the director of the Biomedical Advanced Research and Development Authority because he was raising the alarm about the coronavirus early this year and also resisting pressure from the Trump administration to promote an “unproven drug, hydroxychloroquine, to the American people without transparent information on the potential health risks.”
